Lv5
1194 积分 2025-08-24 加入
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
4小时前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
8天前
已完结
Routes to molecular glue degrader discovery
11天前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
27天前
已完结
In vivo CAR-Ts captivate big pharma
27天前
已完结
Cancer drug approvals and setbacks in 2025
28天前
已完结
The evolution of the obesity drug market
1个月前
已完结
Lilly’s tirzepatide and Novo Nordisk’s semaglutide vie for top drug spot
2个月前
已关闭
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
2个月前
已完结
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
2个月前
已完结
皖公网安备34019202002308
